These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 18854656

  • 1. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
    Zender L, Kubicka S.
    Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656
    [Abstract] [Full Text] [Related]

  • 2. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW, Poon RT.
    Oncology; 2007 Oct; 72 Suppl 1():30-44. PubMed ID: 18087180
    [Abstract] [Full Text] [Related]

  • 3. Systemic therapies in hepatocellular carcinoma.
    Wörns MA, Weinmann A, Schuchmann M, Galle PR.
    Dig Dis; 2009 Oct; 27(2):175-88. PubMed ID: 19546557
    [Abstract] [Full Text] [Related]

  • 4. Targeted therapy of hepatocellular cancer.
    Wysocki PJ.
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [Abstract] [Full Text] [Related]

  • 5. Growth factors as therapeutic targets in HCC.
    Furuse J.
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):8-15. PubMed ID: 18434184
    [Abstract] [Full Text] [Related]

  • 6. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
    Kudo M.
    Dig Dis; 2011 Jul; 29(3):273-7. PubMed ID: 21829017
    [Abstract] [Full Text] [Related]

  • 7. [Hepatocellular carcinoma].
    Kondo S, Ueno H, Morizane C, Okusaka T.
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
    [Abstract] [Full Text] [Related]

  • 8. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
    Zhu AX.
    Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
    [Abstract] [Full Text] [Related]

  • 9. Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents.
    Chaparro M, González Moreno L, Trapero-Marugán M, Medina J, Moreno-Otero R.
    Aliment Pharmacol Ther; 2008 Dec 01; 28(11-12):1269-77. PubMed ID: 18808443
    [Abstract] [Full Text] [Related]

  • 10. Molecularly targeted therapy in hepatocellular carcinoma.
    Huynh H.
    Biochem Pharmacol; 2010 Sep 01; 80(5):550-60. PubMed ID: 20371362
    [Abstract] [Full Text] [Related]

  • 11. Systemic therapy of hepatocellular carcinoma: are we making progress?
    Roxburgh P, Evans TR.
    Adv Ther; 2008 Nov 01; 25(11):1089-104. PubMed ID: 18972075
    [Abstract] [Full Text] [Related]

  • 12. Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
    Kudo M.
    Dig Dis; 2011 Nov 01; 29(3):289-302. PubMed ID: 21829020
    [Abstract] [Full Text] [Related]

  • 13. Future treatment option for hepatocellular carcinoma: a focus on brivanib.
    Kudo M.
    Dig Dis; 2011 Nov 01; 29(3):316-20. PubMed ID: 21829023
    [Abstract] [Full Text] [Related]

  • 14. Molecular targeting for treatment of advanced hepatocellular carcinoma.
    Song IH.
    Korean J Hepatol; 2009 Sep 01; 15(3):299-308. PubMed ID: 19783879
    [Abstract] [Full Text] [Related]

  • 15. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M.
    Oncology; 2008 Sep 01; 75 Suppl 1():1-12. PubMed ID: 19092266
    [Abstract] [Full Text] [Related]

  • 16. Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?
    Finn RS.
    Clin Cancer Res; 2010 Jan 15; 16(2):390-7. PubMed ID: 20068087
    [Abstract] [Full Text] [Related]

  • 17. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M, Biasi F, Feo F, Pascale RM.
    Mol Aspects Med; 2010 Apr 15; 31(2):179-93. PubMed ID: 20176048
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA, Weinmann A, Pfingst K, Schulte-Sasse C, Messow CM, Schulze-Bergkamen H, Teufel A, Schuchmann M, Kanzler S, Düber C, Otto G, Galle PR.
    J Clin Gastroenterol; 2009 Apr 15; 43(5):489-95. PubMed ID: 19247201
    [Abstract] [Full Text] [Related]

  • 19. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
    Rimassa L, Santoro A.
    Expert Rev Anticancer Ther; 2009 Jun 15; 9(6):739-45. PubMed ID: 19496710
    [Abstract] [Full Text] [Related]

  • 20. Systemic therapy for hepatocellular carcinoma.
    Thomas MB.
    Cancer J; 2008 Jun 15; 14(2):123-7. PubMed ID: 18391618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.